Nature Annual Review: Restoring Faith in 2025
On December 17, 2025, the prestigious international scientific journal Nature published an annual review titled “Seven feel-good science stories to restore your faith in 2025.”
The article points out that despite numerous challenges facing the global scientific community in 2025, scientists have still achieved remarkable breakthroughs in fields such as gene editing, disease treatment, environmental protection, and renewable energy. From the success of the first gene therapy for Huntington’s disease to China becoming the first country in the world to surpass 1 terawatt in installed solar capacity; from the population recovery of endangered species to the effective containment of the Ebola outbreak within 42 days—these achievements not only demonstrate the strong resilience of scientific research but also provide new hope for humanity in addressing future challenges.
These advancements span multiple fields, including medicine, energy, and ecological conservation, reflecting the innovation and collaborative spirit of the global scientific community in the face of challenges, and laying a solid foundation for 2025 and the broader future.
Drawing on this Nature article and related research literature, this paper provides an in-depth interpretation of the major scientific advances in 2025 and their far-reaching significance.
In 2025, the global scientific community achieved milestone breakthroughs across multiple key fields. These accomplishments not only demonstrate the continuous progress of scientific research but also highlight humanity’s innovative capacity in addressing complex challenges. From medical treatments to environmental protection, and from energy transition to disease prevention and control, advancements in various sectors have resonated with one another, collectively painting a hopeful picture.
In the medical field,Gene Editing Technology (Gene Editing)ushered in unprecedented breakthroughs. This year was hailed by chemical biologist David Liu as the “breakthrough year for gene editing,” with the success of multiple clinical trials marking a major turning point in the transition of gene therapy from the laboratory to clinical application.Huntington's DiseaseAs a hereditary neurodegenerative disease, it has long lacked effective treatments. In 2025, the first gene therapy targeting this condition demonstrated significant efficacy in clinical trials, slowing the rate of cognitive decline in patients by 75%. This breakthrough not only brings hope to patients with Huntington’s disease but also provides new insights for the treatment of other neurodegenerative disorders.
Meanwhile, gene editing-basedCAR-T Cell Therapy (Chimeric Antigen Receptor T-cell Therapy) has also made significant progress in the treatment of T-cell acute lymphoblastic leukemia.This novel therapy employs base editing technology to simultaneously modify multiple genes in T cells, enabling these immune cells to more precisely identify and attack cancer cells. Among the 11 pediatric and adult patients enrolled in the trial, the majority achieved remission, demonstrating the significant potential of gene-editing technology in the field of cancer treatment.
InDisease Prevention and ControlIn terms of this aspect, 2025 witnessed the rapid response capability of the public health system.In September, an Ebola outbreak occurred in the Kasai Province of the Democratic Republic of the Congo, prompting local health authorities and international organizations to rapidly activate emergency response mechanisms.Although the outbreak occurred in a remote area, posing challenges for healthcare workers to access the region, this geographic isolation also helped limit the spread of the virus to some extent. Through the rapid deployment of vaccines and monoclonal antibody therapies, the outbreak was effectively controlled within 42 days, with a total of 64 cases reported, the last of which appeared on September 25. This successful case demonstrates significant progress made by the global public health system in responding to emerging infectious diseases, particularly in terms of coordinated capabilities in vaccine development, rapid diagnosis, and community engagement.
InEcological ProtectionIn this field, 2025 also yielded encouraging results.Green Sea Turtle (Chelonia mydas)Listed as endangered since the 1980s, it has now been moved from the endangered species list to the “Least Concern” category after years of conservation efforts. This shift is attributed to protective measures for sea turtle eggs and preventive strategies to avoid accidental capture in fishing nets. Similarly, Australia’sMulgara (Ampurta, Dasycercus hillieri)It has also recovered from a near-extinction status to the "Least Concern" level. Between 2015 and 2021, despite challenges such as drought and food shortages, the habitat of the quoll expanded by more than 48,000 square kilometers.
September,United Nations High Seas TreatyApproved by over 60 countries, marking a historic milestone in ocean conservation. The treaty will enter into force in January 2026, aiming to protect biodiversity in international waters through legal measures and conserve at least 30% of land and marine areas. The achievement of this global agreement reflects the shared determination of the international community to address the marine ecological crisis.
AtEnergy TransitionIn terms of this aspect, 2025 witnessed a historic turning point in the development of renewable energy.Global Renewable Energy Generation Surpasses Coal for the First Time, Becoming the Largest Energy Source.This achievement is largely attributable to China’s rapid development in the solar energy sector. In May, China became the first country globally to surpass 1 terawatt (1 TW) of installed solar capacity. In the first half of 2025 alone, China added 256 gigawatts (GW) of new solar capacity, equivalent to twice the newly installed capacity in all other regions of the world combined. According to China’s Five-Year Plan, an additional 200–300 GW of solar and wind power capacity is scheduled to be installed starting from 2026.
Europe has also made significant progress in renewable energy. In the second and third quarters of 2025, approximately half of the European Union’s electricity demand was met by renewable sources. According to forecasts from the International Energy Agency, global renewable energy installed capacity is expected to increase by nearly 4,600 gigawatts between 2025 and 2030, double the capacity deployed during the 2019–2024 period. These figures indicate that the global energy transition is accelerating. Although greenhouse gas emissions from fossil fuels reached a new high in 2025, the rapid development of renewable energy provides a crucial foundation for achieving carbon neutrality goals in the future.
Scientific advancements in 2025 were reflected not only in technological breakthroughs but also in innovations in research methodologies, policy formulation, and global collaboration mechanisms. These innovations have provided new momentum for the sustained development of scientific research, while also demonstrating the scientific community’s adaptability and forward-thinking approach in the face of challenges.
In the field of gene editing, the breakthroughs in 2025 were reflected not only in improved therapeutic efficacy but also in the enhanced precision and personalization of the technology.Researchers have conducted the first clinical trial of individualized CRISPR technology applications, marking a significant shift in gene therapy from one-size-fits-all approaches to personalized precision medicine. This personalized approach enables the design of customized treatment regimens based on each patient’s specific genetic mutations, paving new pathways for the treatment of rare diseases.
Chronic Granulomatous Disease (CGD) is a rare immune system disorder. In 2025, the first clinical trial of gene therapy for this condition was launched. Meanwhile, another trial successfully corrected pathogenic mutations that can lead to lung damage and liver disease. These clinical trials have paved the way for developing mutation-specific strategies for rare diseases and demonstrated the significant value of collaboration between academia and industry in treating such conditions. As Annarita Miccio, a gene therapy researcher at Necker-Enfants Malades Hospital in Paris, stated, “These clinical trials have paved the way for developing mutation-specific strategies for rare diseases and demonstrated that collaboration between academia and industry can bring hope of a cure to patients with these conditions.”
In disease treatment, 2025 witnessed significant advances in antimalarial drugs.In November, the World Health Organization approved the first malaria treatment regimen for infants. Currently, approximately 75% of global malaria deaths occur in children under five years of age, making this advancement a significant step toward achieving the goal of global malaria eradication. This therapy, namedCoartem (Artemether-Lumefantrine)pediatric formulation,Provides a safe treatment option for the relatively neglected population of infants and young children. Jane Achan, a pediatric infectious disease specialist at the London Malaria Consortium, noted, “This will undoubtedly have a broad impact on improving malaria treatment in high-risk populations, particularly by enhancing treatment outcomes for infants and young children in settings with drug-resistant malaria parasites.”
2025 also witnessed anotherSuccess of the Antimalarial Drug Ganaplacide-Lumefantrine (GanLum) in Phase III Clinical Trials.The drug successfully treated malaria in 97.4% of participants and was able to clear parasites resistant to artemisinin. If GanLum receives regulatory approval, it will become the first new class of antimalarial drugs in 25 years, providing a new weapon against the growing problem of drug resistance.
In terms of public health policy, 2025 witnessed significant achievements brought about by science-based policy adjustments.Research on peanut allergy serves as a typical case. For many years, medical guidelines advised parents to avoid exposing infants to peanuts to prevent dangerous allergic reactions. However, a landmark study in 2015 found that the opposite was true—when infants began exposure to peanut products at four months of age, their likelihood of developing an allergy was significantly reduced. This finding prompted adjustments to health guidelines between 2015 and 2017.
Data from 2025 show that, compared with 2012,The prevalence of peanut allergy among children under 3 years old in the United States has decreased by 43%.Similarly, approaches that expose infants to a variety of other allergens have also led to a 36% reduction in other food allergies. Dr. Michael Pistiner, a pediatric allergist at Massachusetts General Hospital, stated, “This is an excellent example of translating the results of controlled trials into outcomes at the broader community level.” This successful case demonstrates how scientific evidence can be translated into effective public health policies, ultimately improving population health.
In terms of environmental protection, the progress made in 2025 was reflected not only in species recovery but also in the improvement of global environmental governance mechanisms.Antarctic Ozone Hole Shrinks to Smallest Size Since 2019, Signaling Continued Recovery of Earth’s Protective Upper Atmosphere. The ozone hole was first discovered in 1985 and was caused by human emissions of ozone-depleting chlorofluorocarbons (CFCs), which primarily originated from refrigerants in refrigerators and aerosol sprays. The 1987 Montreal Protocol phased out the production and use of CFCs, successfully curbing emissions of these substances.
Since 1987, the average size of the ozone hole has decreased year by year, reaching a historic minimum in 2019. Data from 2025 indicate that if efforts to identify climate-friendly alternatives to chlorofluorocarbons (CFCs) continue, the ozone hole is expected to fully recover by the late 2060s. This progress demonstrates the effectiveness of international environmental agreements and underscores the critical role of global collaboration in addressing environmental challenges.
In terms of energy policy, the progress made in 2025 reflects the differing strategies and paces of energy transition across countries.China has taken the lead in installed renewable energy capacity through the large-scale deployment of solar and wind power. This rapid deployment has not only reduced the cost of renewable energy but also provided valuable lessons for other developing countries. Glen Peters, a climate policy researcher at the Center for International Climate Research in Oslo, pointed out, “China and many developing countries are deploying solar power, wind power, and electric vehicles at a considerable pace.”
Nevertheless, challenges persist. Despite significant progress in renewable energy, greenhouse gas emissions from fossil fuels reached a record high in 2025. This indicates that although the installed capacity of renewable energy is growing rapidly, more time and effort are required to fully replace fossil fuels as the dominant global energy source. This necessitates not only continued technological innovation but also systemic changes in policy, infrastructure, and consumption patterns.
The scientific achievements of 2025 are not merely isolated technological victories; together, they reveal a new paradigm for the development of science:Cutting-edge technologies are transitioning from the laboratory to real-world applications at an unprecedented pace, while human intervention in the environment has shifted from mere "destruction" to effective "restoration."
First,The "Accessibility" of Science Is Undergoing a Qualitative Leap“Gene editing” and “fully clean energy,” once regarded as science fiction concepts, have materialized in 2025 as clinical therapies and mainstays of the power grid. Gene therapy is no longer confined to small-scale experiments for rare diseases but is beginning to expand toward a broader range of genetic disorders and even common diseases; renewable energy is no longer an expensive supplementary source but has become the economically superior mainstream choice. This shift from “possibility” to “inevitability” will be the core theme of the next decade—the key challenge ahead will no longer lie in breakthroughs in technical principles, but in reducing costs through scaling up, thereby extending these benefits to a larger global population.
Secondly,The "reversibility" of the ecosystem has been strongly validatedThe ongoing recovery of the ozone layer and the population rebound of endangered species demonstrate that policy interventions guided by science are fully capable of reversing seemingly irreversible environmental damage. This provides valuable psychological reassurance and methodological insights for addressing climate change: with coordinated global action and scientific approaches, the Earth’s ecosystems have demonstrated a self-restorative capacity far exceeding expectations.
Finally,“Evidence-Based Decision-Making” Is Becoming the New Standard for Global GovernanceFrom revising peanut allergy guidelines to signing the High Seas Treaty, scientific evidence has directly reshaped public policy and international legal frameworks. This deep integration of science and decision-making has overcome the limitations of isolated technological breakthroughs, establishing a virtuous cycle supported by technology, policy, and public awareness. Looking ahead, this cross-dimensional collaborative innovation will be our most powerful tool for addressing complex global challenges such as pandemics and the climate crisis.
Scientific Advances in 2025 Spanned Medicine, Energy, and Ecological Conservation, Demonstrating the Resilience and Innovative Capacity of Scientific Research. From Breakthrough Applications of Gene-Editing Technologies to Historic Shifts in Renewable Energy, and from the Recovery of Endangered Species to Progress in Global Environmental Governance, These Achievements Not Only Addressed Immediate Practical Issues but Also Laid a Solid Foundation for Future Development. Despite Numerous Remaining Challenges, the Scientific Progress Made in 2025 Has Provided New Hope and Confidence for Humanity in Confronting Future Challenges, Underscoring the Enduring Value and Long-Term Significance of Scientific Research.